Personalized Escitalopram Dosing in Patients With Depression
Condition: Depressive Disorder, Major Intervention: Drug: Escitalopram Sponsors: University of Belgrade; Clinical Centre of Serbia; Institute of Mental Health, Serbia; Military Medical Academy, Belgrade, Serbia Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 27, 2022 Category: Research Source Type: clinical trials
A Comparative Study on Efficacy and Safety of add-on Sulforaphane or rTMS to Escitalopram for Major Depressive Disorder With Poor Response to Initial Treatment
Condition: Major Depressive Disorder Interventions: Dietary Supplement: Escitalopram+Sulforaphane; Device: Escitalopram+rTMS; Drug: Escitalopram Sponsor: Shanghai Mental Health Center Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 6, 2021 Category: Research Source Type: clinical trials